The expanding popularity in peptides has resulted a large grey industry, presenting grave risks to consumers. These products are frequently manufactured outside strict regulatory oversight, suggesting their quality and efficacy can be very variable. In addition, these sources may lack truthful details regarding materials, possible adverse reactions